We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Thrombolytic Therapy for Pulmonary Embolism

Joshua A. Beckman, MD1
[+] Author Affiliations
1Cardiovascular Division, Brigham and Women’s Hospital, Boston, Massachusetts
JAMA. 2014;311(23):2385-2386. doi:10.1001/jama.2014.5993.
Text Size: A A A
Published online


Pulmonary embolism (PE) accounts for nearly 200 000 hospital discharges and contributes to nearly 30 000 deaths in the United States each year.1 Treatment of PE requires balancing the benefits of anticoagulation with the risk of bleeding. Determining the value of a therapy, incorporating both therapeutic and adverse effects, requires understanding net clinical benefit, the weighing of net benefit (or harm) for a specific therapy.2 Currently, anticoagulation is standard therapy for patients with PE because the risk of fatal bleeding is low compared with the benefit of reduced mortality and recurrent PE. In contrast, more than 40 years after the first trial of thrombolysis was published, the role of thrombolytic therapy in PE remains unclear, because no single clinical trial has provided a definitive answer about its benefit. Furthermore, because of the increased risk of major bleeding, there is uncertainty about which patients may benefit from thrombolysis.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Surgical Treatment of Acute Massive Pulmonary Embolism. Adv Exp Med Biol Published online Sep 13, 2016;

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Pulmonary Embolus

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Make the Diagnosis: Pulmonary Embolus